v3.26.1
Accrued Expenses
3 Months Ended
Mar. 31, 2026
Accrued Expenses  
Accrued Expenses

Note 3. Accrued Expenses

The following is a summary of the Company’s accrued expenses:

March 31, 

December 31, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

Clinical trial expenses

$

2,239,522

$

1,709,542

Other

 

390,894

 

272,088

Total

$

2,630,416

$

1,981,630